Antonides and colleagues present fundamental concepts of cost–effectiveness analysis (CEA) and they discuss the interpretation of these analyses. CEAs of new treatment strategies are being increasingly reported in the literature and national reports, and governments and healthcare payers frequently require a CEA to aid in the decision of whether to fund a new treatment or not. The authors consider a real-world example CEA, comparing transcatheter to surgical aortic valve replacement for intermediate-risk patients.
You are here:
Statistical Primer: A Cost–Effectiveness Analysis
Submitted by: Claire Vernon
Source: European Journal of Cardio-Thoracic Surgery
Source URL: https://doi.org/10.1093/ejcts/ezy187
Keywords:
Author(s): Christiaan FJ Antonides, David J Cohen, Ruben LJ Osnabrugge
